Mettler-Toledo International Inc.· MTD
🇺🇸 US · LargeSP500NYSE
- Price
- $1,437.00
- Day
- -0.55%
- Mkt Cap
- $29.04B
- 52W Range
- $1,023.05 – $1,525.17
- Volume
- 135.4K
- Beta
- 1.25
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Empowered Funds LLC increased its position in Mettler-Toledo International, Inc. (NYSE: MTD) by 63.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,722 shares of the medical instruments supplier's stock after acquiring an additional 1,061 shares during the quarter. Empowered Funds
Read full article
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced today that Natalia Shuman has been appointed to its Board of Directors effective August 3, 2026. Ms. Shuman has served as President and Chief Executive Officer of MISTRAS Group, a global leader in technology-enabled industrial asset integrity solutions, since January 2025 and is a member of its Board of Directors. Prior to joining MISTRAS, she was Executive Vice President and a member of the Group Operating.
Read full article
MTD beats Q2 earnings estimates as strong China and emerging-market sales fuel growth, while the company raises its 2026 sales and earnings outlook.
Read full article
Axiom Investment Management LLC acquired a new position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 676 shares of the medical instruments supplier's stock, valued at approximately $853,000. Several other hedge funds and
Read full article
Mettler-Toledo International NYSE: MTD reported second-quarter results that exceeded its prior sales-growth expectations, supported by improving market conditions, particularly in China and other emerging markets, as well as its sales and marketing initiatives.
Read full article
While the top- and bottom-line numbers for Mettler-Toledo (MTD) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read full article
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2026. Provided below are the highlights: Reported sales increased 4% compared with the prior year. In local currency, sales increased 6% excluding a one-time tariff refund to customers. Net earnings per diluted share as reported (EPS) were $11.55, compared with $9.76 in the prior-year period. Adjusted EPS was $11.46, an increase of 14% over the prior-year amount of $10.09. A.
Read full article
Besides Wall Street's top-and-bottom-line estimates for Mettler-Toledo (MTD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Read full article
Dimensional Fund Advisors LP grew its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 4.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 106,023 shares of the medical instruments supplier's stock after purchasing an additional 4,340 shares during
Read full article
Bank of Nova Scotia lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 50.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,618 shares of the medical instruments supplier's stock after selling 3,679 shares during the
Read full article
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
Mettler-Toledo (MTD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read full article